5VM

5AM Venture Management Portfolio holdings

AUM $273M
1-Year Est. Return 24.59%
This Quarter Est. Return
1 Year Est. Return
+24.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
+$12.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1 +$8.82M

Top Sells

1 +$24.4M
2 +$13.3M
3 +$10.3M
4
VKTX icon
Viking Therapeutics
VKTX
+$5.02M
5
SCPH
scPharmaceuticals
SCPH
+$4.57M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYE icon
1
Skye Bioscience
SKYE
$38.8M
$38M 13.94%
9,681,763
-231,405
TRDA icon
2
Entrada Therapeutics
TRDA
$379M
$24.7M 9.04%
4,256,379
-52,000
PHVS icon
3
Pharvaris
PHVS
$1.69B
$19.9M 7.29%
797,600
CAMP icon
4
CAMP4 Therapeutics
CAMP
$152M
$17.6M 6.45%
5,869,091
+2,941,176
CNTA
5
Centessa Pharmaceuticals
CNTA
$4.21B
$16.5M 6.05%
680,945
-150,000
VRDN icon
6
Viridian Therapeutics
VRDN
$3B
$15.9M 5.82%
736,595
ELVN icon
7
Enliven Therapeutics
ELVN
$1.18B
$15.8M 5.79%
772,477
EYPT icon
8
EyePoint Pharmaceuticals
EYPT
$1.18B
$15M 5.48%
1,050,000
DNTH icon
9
Dianthus Therapeutics
DNTH
$1.85B
$14.4M 5.26%
365,053
-619,672
TYRA icon
10
Tyra Biosciences
TYRA
$1.11B
$13.1M 4.81%
939,298
CLDX icon
11
Celldex Therapeutics
CLDX
$1.72B
$12.9M 4.71%
497,270
ERAS icon
12
Erasca
ERAS
$851M
$11.8M 4.32%
5,405,404
PRAX icon
13
Praxis Precision Medicines
PRAX
$4.62B
$9.01M 3.3%
170,000
GHRS icon
14
GH Research
GHRS
$881M
$8.19M 3%
572,665
TECX
15
Tectonic Therapeutic
TECX
$383M
$8.03M 2.94%
511,660
BHVN icon
16
Biohaven
BHVN
$1.24B
$7.19M 2.63%
478,972
ARTV
17
Artiva Biotherapeutics
ARTV
$85.2M
$6.75M 2.47%
2,353,304
SRZN icon
18
Surrozen
SRZN
$138M
$3.99M 1.46%
310,000
TARA icon
19
Protara Therapeutics
TARA
$260M
$3.48M 1.27%
800,000
ALEC icon
20
Alector
ALEC
$134M
$2.95M 1.08%
995,841
SLN
21
Silence Therapeutics
SLN
$311M
$2.47M 0.91%
476,200
ADVM icon
22
Adverum Biotechnologies
ADVM
$92.7M
$2.45M 0.9%
541,666
RLYB icon
23
Rallybio
RLYB
$27.4M
$1.81M 0.66%
3,630,724
ZNTL icon
24
Zentalis Pharmaceuticals
ZNTL
$99M
$740K 0.27%
490,000
MRSN icon
25
Mersana Therapeutics
MRSN
$137M
$405K 0.15%
52,200